Romiplostim

In the US, Romiplostim (romiplostim systemic) is a member of the drug class platelet-stimulating agents and is used to treat Idiopathic Thrombocytopenic Purpura.

US matches:

• Romiplostim


• Romiplostim Subcutaneous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

B02BX04

CAS registry number (Chemical Abstracts Service)

0267639-76-9

Chemical Formula

C2634-H4086-N722-O790-S18

Molecular Weight

59085

Therapeutic Categories

Platelet stimulating factor

Thrombopoietin receptor agonist

Chemical Names

L-methionyl [human immunglobulin heavy constant gamma 1-(227 C-terminal residues)-peptide (Fc fragment)] fusion protein with 41 amino acids peptide, (7-7':10,10')-bisdisulfide dimer (WHO)

Methionyl, 227 amino acid C-terminal Immunoglobulin G1 (human Fc fragment) fusion protein with 41 amino acid peptide, dimer (USAN)

Foreign Names

• Romiplostimum (Latin)
• Romiplostim (German)
• Romiplostim (French)
• Romiplostim (Spanish)

Generic Names

• Romiplostim (OS: USAN)
• AMG 531 (IS: Amgen)

Brand Names

• Nplate
  Amgen, Australia; Amgen, Canada; Amgen, Germany; Amgen, Spain; Amgen, France; Amgen, United Kingdom; Amgen, Greece; Amgen, Sweden; Amgen, Slovakia; Amgen, United States; Amgen Europe, Austria; Amgen Switzerland, Switzerland

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.